Prudential Financial’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-61,459
| Closed | -$7.32M | – | 2570 |
|
|
2024
Q3 | $7.32M | Sell |
61,459
-1,785
| -3% | -$213K | 0.01% | 810 |
|
|
2024
Q2 | $9.03M | Buy |
63,244
+3,965
| +7% | +$566K | 0.01% | 678 |
|
|
2024
Q1 | $7.61M | Buy |
59,279
+5,257
| +10% | +$675K | 0.01% | 766 |
|
|
2023
Q4 | $5.59M | Buy |
54,022
+4,069
| +8% | +$421K | 0.01% | 882 |
|
|
2023
Q3 | $4.54M | Buy |
49,953
+357
| +0.7% | +$32.5K | 0.01% | 935 |
|
|
2023
Q2 | $4.01M | Buy |
49,596
+14,776
| +42% | +$1.2M | 0.01% | 1005 |
|
|
2023
Q1 | $1.94M | Buy |
34,820
+554
| +2% | +$30.9K | ﹤0.01% | 1362 |
|
|
2022
Q4 | $2.32M | Buy |
34,266
+1,830
| +6% | +$124K | ﹤0.01% | 1230 |
|
|
2022
Q3 | $1.63M | Buy |
32,436
+2,588
| +9% | +$130K | ﹤0.01% | 1458 |
|
|
2022
Q2 | $1.64M | Buy |
29,848
+14,520
| +95% | +$799K | ﹤0.01% | 1504 |
|
|
2022
Q1 | $851K | Buy |
15,328
+4,344
| +40% | +$241K | ﹤0.01% | 1950 |
|
|
2021
Q4 | $636K | Sell |
10,984
-152
| -1% | -$8.8K | ﹤0.01% | 2107 |
|
|
2021
Q3 | $565K | Buy |
11,136
+1,180
| +12% | +$59.9K | ﹤0.01% | 2099 |
|
|
2021
Q2 | $417K | Buy |
9,956
+528
| +6% | +$22.1K | ﹤0.01% | 2193 |
|
|
2021
Q1 | $318K | Buy |
9,428
+60
| +0.6% | +$2.02K | ﹤0.01% | 2259 |
|
|
2020
Q4 | $327K | Buy |
9,368
+1,688
| +22% | +$58.9K | ﹤0.01% | 2219 |
|
|
2020
Q3 | $267K | Buy |
7,680
+1,270
| +20% | +$44.2K | ﹤0.01% | 2204 |
|
|
2020
Q2 | $210K | Buy |
+6,410
| New | +$210K | ﹤0.01% | 2246 |
|